Evolent Health (EVH) PT Raised to $7 at Truist Securities

June 11, 2026 4:01 PM

Truist Securities analyst Jailendra Singh raised the price target on Evolent Health (NYSE: EVH) to $7.00 (from $6.00) while maintaining a Buy rating.

No results found